PRRT2 and Cognitive impairment: Impaired ERK/CREB/BDNF signalling pathway and an inhibition of CaMK-II/PKC/PKA-ERK-CREB signalling lead to cognitive deficit and disruption of long-term potentiation in the hippocampus [49].